Plain-English translation of NCT07141121 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This feasibility study is testing whether the Histolog Scanner can help doctors check the margins (edges) of prostate tissue removed during surgery more quickly and efficiently. Currently, a method called NeuroSafe is used to check these margins, but it takes a long time and adds cost. Researchers want to see if the Histolog Scanner can do the same job faster, so patients can benefit from nerve-sparing surgery without the extra time and expense.
Checking the edges of removed prostate tissue is important to make sure all cancer is removed and to preserve nerves that affect sexual and urinary function. However, the current process is time-consuming and costly in the United States. This study exists to see if a newer imaging technology can accomplish the same safety goals more efficiently and affordably.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will undergo your scheduled robotic-assisted prostate removal surgery as planned. After the surgery, instead of using the standard time-intensive margin-checking method, your removed prostate tissue will be scanned with the Histolog Scanner. You will also have standard blood tests, a rectal exam, an MRI, and micro ultrasound imaging, and researchers will review your medical records throughout the study. The study evaluates whether this new imaging approach saves time while maintaining the safety and accuracy of margin assessment.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
United States